Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Adipose-secreted signaling protein (ADISSP) is a secreted adipokine, primarily expressed in brown adipose tissue (BAT) and beige adipocytes, and it plays a crucial role in the regulation of white adipose tissue (WAT) thermogenesis and glucose homeostasis[1][5][6]. Its secretion is stimulated by β3-adrenergic activation, and it acts by binding a putative receptor at the adipocyte surface, promoting PKA pathway activation independently of β-adrenergic signaling[1]. Functional studies in mice reveal that ADISSP is necessary for efficient WAT browning, protecting against diet-induced obesity and hyperglycemia. Physiologically, it acts as a bioactive mediator in adipose tissue function and metabolic health. This makes it a promising candidate for therapeutic development targeting obesity and type 2 diabetes, potentially with reduced off-target safety risks due to its restricted expression profile[1][2][3][5][6].
Activation of protein kinase A (PKA) pathway in adipocytes
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Adipose-secreted signaling protein (ADISSP).